Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference96 articles.
1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016
2. Optimal management of hormone receptor positive metastatic breast cancer in 2016;Reinert;Ther Adv Med Oncol.,2015
3. Endocrine therapy in the current management of postmenopausal estrogen receptor-positive metastatic breast cancer;Kaklamani;Oncologist,2017
4. The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors;Rugo;Ann Oncol.,2008
5. Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer;Nagaraj;Breast Cancer Res Treat.,2015
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The anti-aromatase and anti-estrogenic activity of plant products in the treatment of estrogen receptor-positive breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2024-10
2. Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USA;Future Oncology;2024-05-17
3. Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study;Expert Opinion on Drug Safety;2024-05-16
4. Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies;Biochemical Pharmacology;2024-05
5. Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy;Frontiers in Pharmacology;2024-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3